Biologics research and production have grown rapidly in the past few decades, with no signs of slowing down. As innovators navigate a varied landscape of biological drugs designed to target everything from cancer to infectious diseases, many challenges still face those developing these next-generation therapeutics.
Read this white paper to uncover global trends in biologics-focused drug discovery, factors contributing to continued growth in the space, and the challenges of investing in this shifting market.
